Please note: AABB reserves the right to make updates to this program.
Wednesday, July 29, 2026
2:00 – 3:00 PM Eastern Time
Program Number: 26EL-658
Director/Moderator: Herleen Rai, MD, Assistant Professor, Department of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Speakers:
Cyberattacks on healthcare systems are becoming more frequent, with significant implications for transfusion medicine services. This eCast will explore recent cybersecurity events affecting transfusion support, share lessons learned from real-world experiences, and highlight evolving threats. The faculty will also discuss practical strategies for maintaining patient care during system outages, including communication workflows and crisis leadership approaches. Participants will gain tools to assess their current preparedness and identify steps to strengthen transfusion service resilience in the face of future cyber threats.
After participating in this educational activity, participants should be able to:
Registration includes access to both the live and on-demand version of this eCast.
If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.
Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.
| Single Viewer | Register |
| Group Viewing | Register |
This activity is eligible for one (1) continuing education credit/contact hour for Physicians, California Nurses, California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.
There is no financial support for this activity.
In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB), which is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): AABB designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. AABB designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claiming Credit
Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.
Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).
Program & Credit Expiration Dates:
Disclosure Declaration
It is the policy of the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of its CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AABB has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and AABB personnel are provided at the beginning of the program.
Dr. Richard Gammon is the Medical Director of Transfusion Medicine and the Blood Bank at Moffitt Cancer Center and Research Institute in Tampa, Florida. He received his medical degree at Drexel University, completed his residency training in Clinical Pathology at The Ohio State University and fellowship training in Blood Banking and Transfusion Medicine at the University of Virginia Medical Center. Dr. Gammon has board certifications in Clinical Pathology, as well as Blood Banking/Transfusion Medicine. He is a member of the faculty of the University of South Florida. He is active in AABB, ISBT as the Clinical Transfusion Working Party chair, and the President of the South-Central Association of Blood Banks.
Dr. Sarah Harm is the Network Vice Chair of Laboratory Medicine and Network Medical Director of Blood Bank in the University of Vermont Health Network. She is also a Professor in Pathology and Laboratory Medicine at the Larner College of Medicine at the University of Vermont. She completed her Clinical Pathology residency and fellowship in Blood Bank/ Transfusion Medicine at the University of Pittsburgh Medical Center in Pittsburgh, PA. Sarah is originally from Nazareth, PA and spent many years between Boston and Philadelphia for education and work in the pharmaceutical industry prior to medical school. She lives in South Burlington, VT with her husband, three kids and two dogs, who all enjoy mountain biking, gravel riding, backcountry and alpine skiing, soccer, and lacrosse.
Dr. Herleen (Sofi) Rai is an Assistant Professor in the Department of Pathology at the Johns Hopkins University School of Medicine and serves as Associate Program Director of the Pathology Residency Training Program at JHH. Dr. Rai obtained her MD from Ross University School of Medicine and completed her residency training in Clinical Pathology at Case Western Reserve University School of Medicine/ University Hospitals Cleveland Medical Center. This was followed by a two-year fellowship in Transfusion Medicine at the National Institutes of Health (NIH). As a faculty member of the Division of Transfusion Medicine, her areas of interest include stem cell and immune effector cell therapies, with a focus on apheresis collection and manufacturing. She serves as the Associate Medical Director for Apheresis at the Johns Hopkins Hospital and has been part of AABB's e-Learning Committee for two years.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
